BEVERLY HILLS, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (“TOMI”) (OTCQX:TOMZ),
a global decontamination company that specializes in disinfection/decontamination sales and services, including SteraMist™, a
hydrogen peroxide-based mist/fog registered with the U.S. Environmental Protection Agency (“EPA”) for use as a hospital-healthcare
disinfectant, was added to the list of approved suppliers for the healthcare improvement company, Premier, effective November
3rd.
Group purchasing organizations (GPOs) were originally established to pool the purchasing power of hospitals and other healthcare
providers in order to receive significant discounts on much needed medical supplies. Premier, which operates a leading GPO, unites
thousands of U.S. hospitals and more than 150,000 additional provider organizations. For TOMI™, this inclusion offers another
opportunity to further penetrate the hospital healthcare market.
This multi-use, broad-based technology can be incorporated into all areas of a hospital environment and many hospitals across
the country have already successfully integrated the SteraMist technology into their routine cleaning protocols. SteraMist is
currently on the EPA’s List K for Registered Antimicrobial Products. Additionally, TOMI™ has met the requirements and submitted to
be included on EPA Lists L and M.
TOMI is excited to start building a mutually beneficial relationship with the Premier network to deliver the best disinfection
technology on the market today. Elissa Shane, Operations and Compliance Officer for TOMI, stated, “We are excited to join Premier’s
supplier list and are committed to delivering the best products with the best value to its members.”
About TOMI Environmental Solutions, Inc.
TOMI Environmental Solutions, Inc. (OTCQX:TOMZ) is a global decontamination and infection prevention company, providing
environmental solutions for indoor surface disinfection through manufacturing, sales and licensing of its premier Binary Ionization
Technology® (BIT™) platform, which was invented under a defense grant in association with the Defense Advanced Research Projects
Agency (DARPA) of the U.S. Department of Defense. BIT™ uses a low percentage Hydrogen Peroxide as its only active ingredient to
produce a hydroxyl radical (OH ion), represented by the TOMI™ SteraMist™ brand of products, which produces a germ-killing aerosol
that works like a visual non-caustic gas.
TOMI’s products are designed to service a broad spectrum of commercial structures including but not limited to
hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce
processing facilities (when not in operation), military barracks, police and fire departments, and athletic facilities. TOMI’s
products and services have also been used in single-family homes and multi-unit residences.
TOMI also develops training programs and application protocols for its clients and is a member in good standing
of The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection
Control and Epidemiology, Society for Healthcare Epidemiology of America and The Restoration Industry Association.
For additional information, please visit http://www.tomimist.com/ or contact us at info@tomimist.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
Certain written and oral statements made by us may constitute “forward-looking statements” as defined in the
Private Securities Litigation Reform Act of 1995 (the “Reform Act”). Forward-looking statements are identified by such words and
phrases as “we expect,” “expected to,” “estimates,” “estimated,” “current outlook,” “we look forward to,” “would equate to,”
“projects,” “projections,” “projected to be,” “anticipates,” “anticipated,” “we believe,” “could be,” and other similar phrases.
All statements addressing operating performance, events, or developments that we expect or anticipate will occur in the future,
including statements relating to revenue growth, earnings, earnings-per-share growth, or similar projections, are forward-looking
statements within the meaning of the Reform Act. They are forward-looking, and they should be evaluated in light of important risk
factors that could cause our actual results to differ materially from our anticipated results. The information provided in this
document is based upon the facts and circumstances known at this time. We undertake no obligation to update these forward-looking
statements after the date of this release
MEDIA RELATIONS CONTACT
Juliana deRosa
Executive Administrator
jderosa@tomimist.com